Form 8-K - Current report:
SEC Accession No. 0001193125-16-574906
Filing Date
2016-05-03
Accepted
2016-05-03 16:03:05
Documents
2
Period of Report
2016-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d190696d8k.htm 8-K 16943
2 EX-10.1 d190696dex101.htm EX-10.1 31069
  Complete submission text file 0001193125-16-574906.txt   49197
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 161615415
SIC: 2834 Pharmaceutical Preparations